Interestingly, our results showed that serum APRIL discriminated RA patients from controls with AUC = 1, with sensitivity, specificity, positive and negative predictive values of 100% at cutoff value of > 4.19 ng/ml (Table 4), suggesting APRIL as an excellent discriminator. The gene discussed is TNFSF13; the disease is rheumatoid arthritis.